OCCABUZZ//
▛ TS // OCCABUZZ // HUMINT — DECRYPTEDCLASSIFIED 
THE HIVE / DOSSIER 003
DOSSIER 003 · S // METABOLIC // TELEMETRY

METABOLIC EDGE // CGM ARCHITECTURE

MOLECULAR LONGEVITYGRADE: EMERGINGBEHAVIORAL TOOL · HARD OUTCOMES UNPROVEN IN HEALTHY
CALIBRATED CERTAINTY 55%

Continuous glucose monitoring, now available over-the-counter in the US for non-diabetics, turns the invisible metabolic response to food, stress and sleep into a live stream. Its proven value in a metabolically healthy operator is behavioral: it exposes personal glycemic spikes and lets you flatten variability. What it does not yet have is strong outcome data that flattening those curves extends healthspan in people who are already healthy.

Acts on: METABOLIC / DIGESTIVE
ACTS ON: METABOLIC / DIGESTIVE
▚ INTELLIGENCE READOUT
SIGNAL
Real-time interstitial glucose, 24/7
US AVAILABILITY
OTC for non-diabetics (Lingo / Libre / Stelo class)
PROVEN VALUE
Behavioral — identify & dampen personal spikes
HARD OUTCOME DATA (HEALTHY)
Limited / not established
▚ FIELD STACK // RECOMMENDED DEPLOYMENT
◈ OPERATIONAL IMPACT

Fewer post-meal crashes means steadier energy and cognition across the working day. The win is discovering which of your specific meals sabotage the next two hours.

⧗ WHERE CERTAINTY ENDS

In healthy people the benefit is feedback-driven behavior change, not a demonstrated longevity effect. Interstitial glucose lags blood; treat as trend.

⛓ SOURCE INTEGRITY
OCCABUZZ // Dossier 003 — CGM Architecture